In this session, Elizabeth Wells (PhD candidate at the University of South Australia), librarian and former teacher, presents on cancer-related cognitive impairment (CRCI) — often called cancer fog or brain fog.
Elizabeth explains who can experience CRCI (across many cancer types and treatments), the common symptoms (attention, memory, processing speed, executive function), and why it can be difficult to test in a “real life” environment despite standard cognitive assessments. She outlines current theories about what may contribute to CRCI (including inflammation, treatment effects, and patient factors like stress and sleep), and shares practical coping strategies such as simple organisation tools, pacing, exercise where appropriate, mental stimulation that’s enjoyable, and talking openly with your healthcare team and support networks.
A major focus of the talk is Elizabeth’s PhD research exploring whether listening to stories (being read to) — rather than reading independently — might support emotional wellbeing and restore the benefits of reading for people experiencing CRCI during treatment. She introduces bibliotherapy (reading for therapeutic benefit), describes its historical use and emerging evidence across wellbeing, pain and sleep, and invites participants to join her reading-aloud research project (including via Zoom for those outside Adelaide).
Keep watching
Watch our other webinars
-
Blood, bones and the tip of the iceberg: Myeloma markers and monitoring
Professor Simon Harrison provides a clear overview of how myeloma is diagnosed, monitored and assessed over time.
-
Common myeloma side effects and strategies to improve quality of life
Haematologist Joy Ho discusses common side effects of myeloma and its treatments, with practical strategies to support quality of life. The presentation covers peripheral neuropathy,…
-
Myeloma Carer’s toolkit
Myeloma Specialist Nurse Lucy Murphy shares practical guidance for people caring for someone with myeloma. She discusses the carer’s role, informed decision-making, practical support, communication,…
-
Bi-specific and tri-specific T cell engagers for the treatment of myeloma
Professor Hang Quach explains how bispecific and trispecific T-cell engagers are changing multiple myeloma treatment. He discusses how these therapies work, current and emerging treatment…
-
Travel and myeloma- National myeloma month 2022
Senior Myeloma Specialist Nurse Jo discusses travel and myeloma, including planning with your treating team, medications, medical letters, vaccinations, travel insurance, infection precautions and practical…
-
National myeloma update 2025
Prof. Miles Prince’s 2025 myeloma update: from chemo to cutting-edge immunotherapies like CAR-T & bispecifics. Learn about new treatments, access, and the future of care
-
Exploring impacts of new technology
Associate Professor Edwin Hawkins explores how myeloma cells interact with the bone marrow microenvironment and evade immune responses. Using advanced imaging and spatial transcriptomics, this…
-
Supportive care and mental health and wellbeing
Psychologist Natalie Tucky discusses mental health, supportive care, self-advocacy, and wellbeing for people living with myeloma and precursor conditions.
-
Your immune system- Supporting immune function
Learn how multiple myeloma affects the immune system, why infection risk is higher, and how treatments like immunoglobulin replacement, vaccines, and antibiotics are used to…
-
Autologous stem cell transplant
Clinical Nurse Consultant Jenny Paul explains the autologous stem cell transplant process for myeloma, covering mobilisation, chemotherapy, reinfusion, side-effect management, and long-term recovery in a…
Connect with us
Stay informed with the latest myeloma research, treatment updates, and support resources. We offer tailored newsletters for both patients and healthcare professionals with relevant information and community updates.
